Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
cardiac glycoside |
| gptkbp:administeredBy |
oral route
intravenous route |
| gptkbp:alternativeName |
Cedilanid
Cedilanide |
| gptkbp:ATCCode |
C01AA05
|
| gptkbp:CASNumber |
17598-65-1
|
| gptkbp:derivedFrom |
gptkb:Digitalis_lanata
|
| gptkbp:foundIn |
gptkb:Digitalis_lanata
|
| gptkbp:hasMolecularFormula |
C49H76O20
|
| gptkbp:hasUNII |
6T1I1V43KX
|
| https://www.w3.org/2000/01/rdf-schema#label |
lanatoside C
|
| gptkbp:is_classified_as |
cardenolide
|
| gptkbp:is_metabolized_to |
gptkb:digoxin
|
| gptkbp:is_used_to_treat |
gptkb:arrhythmia
heart failure |
| gptkbp:IUPACName |
(3β,5β,12β)-3-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-card-20(22)-enolide
|
| gptkbp:KEGGID |
D08141
|
| gptkbp:meltingPoint |
238–240 °C
|
| gptkbp:PubChem_CID |
390008
441436 CHEBI:6365 DB01078 |
| gptkbp:sideEffect |
gptkb:arrhythmia
nausea vomiting |
| gptkbp:usedFor |
gptkb:drug
|
| gptkbp:bfsParent |
gptkb:Digitalis_lanata
|
| gptkbp:bfsLayer |
7
|